Supporting Clinical Decision-Making during the SARS-CoV-2 Pandemic through a Global Research Commitment : The TERAVOLT Experience

Trama, Annalisa; Proto, Claudia; Whisenant, Jennifer G; Torri, Valter; Cortellini, Alessio; Michielin, Olivier; Barlesi, Fabrice; Dingemans, Anne-Marie C; Van Meerbeeck, Jan; Pancaldi, Vera; Mazieres, Julien; Soo, Ross A; Leighl, Natasha B; Peters, Solange; Wakelee, Heather; Horn, Leora; Hellmann, Matthew; Wong, Selina K; Garassino, Marina Chiara; Baena, Javier

doi:10.1016/j.ccell.2020.10.002

Scientific article

English

Supporting Clinical Decision-Making during the SARS-CoV-2 Pandemic through a Global Research Commitment : The TERAVOLT Experience

Published inCancer cell, vol. 38, no. 5, p. 602-604

Publication date2020-11-09

First online date2020-10-05

Abstract

To understand the real impact of COVID-19 on cancer patients, an entirely new data collection effort was initiated within the Thoracic Cancers International COVID-19 Collaboration (TERAVOLT). TERAVOLT reported high mortality related to COVID-19 infection in thoracic cancer patients and identified several negative prognostic factors. In this commentary, we discuss the importance and limits of patient registries to support decision-making in thoracic cancer during the SARS-CoV-2 pandemic.

Keywords

Betacoronavirus / isolation & purification
COVID-19
Clinical Decision-Making
Coronavirus Infections / complications
Coronavirus Infections / virology
Global Burden of Disease / standards
Humans
International Cooperation
Pandemics
Pneumonia, Viral / complications
Pneumonia, Viral / virology
Practice Guidelines as Topic / standards
Registries
SARS-CoV-2
Thoracic Neoplasms / epidemiology
Thoracic Neoplasms / therapy
Thoracic Neoplasms / virology

Affiliation entities

Not a UNIGE publication

Research groups

Découverte de biomarqueurs numériques pour l'oncologie de précision (1059)

Citation (ISO format)

TRAMA, Annalisa et al. Supporting Clinical Decision-Making during the SARS-CoV-2 Pandemic through a Global Research Commitment : The TERAVOLT Experience. In: Cancer cell, 2020, vol. 38, n° 5, p. 602–604. doi: 10.1016/j.ccell.2020.10.002

Article (Published version)

OA OTHER

Identifiers

PID : unige:191792
DOI : 10.1016/j.ccell.2020.10.002
PMID : 33091381
PMCID : PMC7534826

Additional URL for this publicationhttps://www.sciencedirect.com/science/article/pii/S1535610820304967

Journal ISSN1535-6108

5views

23downloads

Creation28/11/2025 17:35:51

First validation20/02/2026 16:25:27

Update20/02/2026 16:25:27

Status update20/02/2026 16:25:27

Last indexation20/02/2026 16:25:28

Archive ouverte UNIGE

Supporting Clinical Decision-Making during the SARS-CoV-2 Pandemic through a Global Research Commitment : The TERAVOLT Experience

Technical informations